2-Chloro-5-methylpyridin-3-amine

Catalog No.: 
ACXWHI534
CAS No.: 
34552-13-1
Molecular Formula: 
C6H7ClN2
Molecular Weight: 
142.59
2-Chloro-5-methylpyridin-3-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g98%$103.00In stockInquiry
500g98%$505.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Chloro-5-methylpyridin-3-amine
IUPAC Name2-chloro-5-methylpyridin-3-amine
MDL No.MFCD03427656
Molecular FormulaC6H7ClN2
Molecular Weight142.59
SMILESCC1=CN=C(Cl)C(N)=C1
InChI KeyCQKIBEOVARIBDN-UHFFFAOYSA-N
SynonymDTXSID50370301 | 3-Amino-2-chloro-5-picoline | CS-D0774 | 3-Amino-2-chloro--5-methylpyridine | 3-AMINO-2-CHLORO-5-METHYLPYRIDINE | STL554964 | AB15085 | 2-chloro-3-amino-5-methylpyridine | SCHEMBL221321 | BBL101168 | Pyridine, 3-amino-2-chloro-5-methyl- |
CAS No.34552-13-1
PubChem CID2734422

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACXWHI534 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACXWHI534 route product structure diagram
    ACXWHI53434552-13-1In Stock
Inquiry

2. ACXWHI534 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXWHI534 route product structure diagram
    ACXWHI53434552-13-1In Stock
Inquiry

3. ACXWHI534 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXWHI534 route product structure diagram
    ACXWHI53434552-13-1In Stock
Inquiry

Comments (0)